Ophthalmology is changing from a reactive to a proactive and predictive field as a result of the combination of machine learning and artificial intelligence (AI), which is offering a fresh perspective on retinal health.
A non-invasive way to observe blood vessels and nerve fibers is through retinal pictures. They serve as a useful diagnostic tool for a variety of illnesses in addition to being a window into the eye.
In individuals with type 1 diabetes, for example, a greater diameter or width of retinal veins is linked to kidney problems, but the narrowing of retinal arterioles, which are tiny blood vessels in the retina, is linked to a long-term risk of high blood pressure.
Additionally, the ratio of arteriolar to venular diameter is a recognized biomarker for heart disease and stroke.
Thus, the retina offers a special chance to evaluate and diagnose a number of conditions, including excessive blood pressure, diabetes mellitus, coronary heart disease, renal disease, and neurodegenerative diseases. This is so because the vascular state of the patient can be inferred from the anatomy of the retinal vessels.
These diseases are becoming more common as a result of bad lifestyle choices and an aging population. The necessity of the hour is to identify high-risk patients and provide early diagnosis.
Imaging of the retina's blood vessels has gained popularity within the last 20 years. Accurate information about our circulatory system is now possible because to technologies that can take retinal images, such as adaptive optics, optical coherence tomography-angiography (OCT-A), and retinal fundus photography.
The retina, optic nerve head, macula, retinal blood vessels, choroid, and vitreous are among the structures inside the eye that can be photographed using fundus photography.
These pictures are used to screen for and identify a number of treatable and avoidable causes of blindness, including glaucoma, age-related macular degeneration, and diabetic retinopathy.
OCT-A is a non-invasive, time-efficient method that provides a three-dimensional view of the retina and is used to get detailed images of the vascular networks of the retina.
Over the past ten years, research has been concentrated on creating software that will allow the retinal vascular network from these imaging methods to be automatically analyzed, giving a precise description of the patient's veins and arteries.
Retinal microvascular biomarkers have recently attracted more attention thanks to a novel technique known as "oculomics," which makes use of datasets of retinal images and artificial intelligence algorithms.
Eye surgery and generative AI
Improving surgical results for patients with macular holes, a disorder that results in central vision loss, is a common issue in ophthalmology that AI can assist in solving.
Defects in the macula, a component of the retina, are known as macular holes. The condition affects the ability to see clearly, particularly in the central field of vision.
If the retinal hole is tiny, vitrectomy—a surgical procedure used to treat it—has a high success rate.
Even though macular hole surgery is the usual treatment for the condition, the results might vary; a failed procedure frequently necessitates a second effort, higher costs, and more emotional strain for the patient.
Here, artificial intelligence (AI) systems that can learn from pre- and post-operative photos can be used. The device can assist in forecasting the post-operative appearance of a patient's retina, including the possibility that the macular hole will close.
This predictive ability is a huge advancement since it gives surgeons a strong tool to properly plan the procedure and give patients preoperative advice, enabling them to make better decisions and setting realistic expectations.
Non-invasive diabetes screening
The need for more easily available and non-invasive diabetes diagnostic tools is driving this author and her team to work on a second, equally significant initiative.
Blood samples are usually needed for the current screening procedures for glycated haemoglobin (HbA1c) levels, which can be inconvenient and create barriers to care. HbA1c is a test that analyzes average blood sugar levels over the preceding 90 days, reported as a percentage.
Given that India is regarded as the world's diabetes capital, this is an especially important issue.
According to the 11th edition of the International Diabetes Federation Atlas, India already has more diabetics than China, and that number is expected to rise by 75% over the next 25 years.
This emphasizes how urgently a scalable, affordable solution that eliminates the need for a blood test is needed. This project's researchers are creating a deep learning system that uses retinal pictures to directly classify HbA1c levels.
The algorithm has trained to recognize patterns in ocular pictures that are linked to an individual's average blood sugar level (HbA1c), making the created model extremely precise and robust.
It can provide a straightforward "yes/no" response regarding whether blood sugar is within a healthy range based on the patterns. Additionally, it can offer a more thorough assessment that categorizes the levels as high risk, elevated, or ideal.
For the nation's sizable diabetic population, the technology can be implemented as an easy-to-use application that can be utilized for mass screening, making it more affordable than conventional blood testing.
Without requiring conventional blood testing, this novel method has the potential to revolutionize routine diabetes screening by enabling earlier detection and intervention.
A unified system for classifying diseases
Subtle signals of many systemic diseases, like excessive blood sugar and cholesterol, first show up in the retina before additional clinical symptoms do.
The larger problem of categorizing several diseases from a retinal image is being addressed by this author and her group.
Auxiliary Classifier Generative Adversarial Networks (AC-GANs), which are very useful for disease classification, are used in this project.
In addition to producing realistic retinal images to supplement sparse datasets, the AC-GAN framework trains a classifier to distinguish between eye disorders and systemic conditions including kidney and heart disorders.
By enabling physicians to screen for a variety of illnesses in a single, effective imaging session, this dual-purpose technology has the potential to simplify diagnoses.
When taken as a whole, these initiatives herald a new era of AI-driven ophthalmology in which retinal scans provide unparalleled insights on the health of the body and eyes.
AI is being used by many researchers worldwide to screen for eye diseases, but applications like predicting an individual's average blood sugar level from an eye scan or creating a single tool that can screen for multiple conditions in the eye and throughout the body are not only unique but also essential, particularly for low-resource nations like India.
0 Comments